Med tech 2.5

Background of the Speaker

  • Jackie Barnet is a virologist who worked for GlaxoSmithKline for nearly 20 years, focusing on developing antivirals.

Introduction to Vaccination

  • Mention of Edward Jenner, known as the father of vaccination.

  • Context of Jenner's discovery:

    • Noticed milkmaids exposed to cowpox developed immunity to smallpox, a disease rampant at that time.

    • Conducted the first vaccination by inoculating his gardener's son with cowpox pus and then exposing him to smallpox, which provided protection.

    • Significance of this event in the history of microbiology and vaccination.

Current State and Technology of Vaccines

  • Transition to discussing modern vaccines, especially those related to COVID-19.

  • Overview of viruses and their impact on health; expressed interest in microorganisms and unseen phenomena such as astronomical elements.

  • Noted that vaccine development has significantly reduced mortality rates.

Understanding Viruses

  • Virus Classification and Structure:

    • Viruses are classified based on their structure and replication method.

    • Two main types of viruses based on genetic material:

      • DNA viruses

      • RNA viruses

    • Viruses are considered obligate intracellular parasites; they are inactive outside of host cells.

    • Viruses lack basic cellular functions and rely heavily on host cells for replication.

Specific Types of Viruses

  • Examples of various viruses include:

    • Influenza viruses (A, B, C); only A and B infect humans.

    • Hepatitis viruses, with five types currently identified.

    • Other notable viruses: Ebola, polio, measles, and rhinoviruses (which cause the common cold with about 110 serotypes).

  • Difficulty in creating a vaccine for the common cold due to the high number of serotypes.

Vaccine Development Considerations

  • The severity of the infection influences vaccine tolerance and acceptance of side effects.

    • Personal anecdote about an autoimmune disease that developed in the speaker's father after the COVID vaccine (AstraZeneca).

  • Importance of evaluating side effects in relation to the severity of the underlying virus, e.g., Ebola vs. influenza.

  • Overview of significant vaccine types, including:

    • Live vaccines

    • Inactivated or killed vaccines

    • Subunit vaccines (e.g., the spike protein from COVID-19)

    • Virus-like particles (e.g., HPV, Hepatitis B vaccines).

  • Emergence of mRNA vaccines (e.g., Pfizer, Moderna) during the COVID pandemic.

Vaccine Mechanisms and Immune Response

Virus Structure

  • Viruses consist of proteins and nucleic acids and may have additional features like spikes or envelopes.

  • After infection, viruses must uncoat their capsid before releasing their genome.

  • Subsequent processes include:

    • Replication of the viral genome

    • Transcription and translation for protein synthesis

    • Assembly and release of new viral particles.

Immune System Response

  • Key participants in the immune response include:

    • B cells (produce antibodies)

    • T cells (help in recognizing and eliminating infected cells).

  • Concept of memory cells and their role in quickly producing antibodies upon re-exposure.

  • Explanation of cytokine storms in severe COVID-19 cases and the importance of understanding T-cell responses.

Herd Immunity

  • Definition: Herd immunity occurs when a majority of a population is vaccinated, reducing transmission likelihood.

  • The relationship between vaccination rates and the resurgence of diseases such as measles due to decreased immunization.

Vaccine Technology Evolution

  • Discussion of the shift from live vaccines due to mutation risks and safety concerns.

  • Overview of advancements in molecular biology that allow for rapid vaccine development, particularly in response to the COVID-19 pandemic.

  • Challenges faced in traditional vaccine development methods (e.g., growing viruses in chicken eggs).

RNA Vaccines and Viral Vectors

  • RNA vaccines encapsulate mRNA in lipid particles for safety and efficacy.

  • Viral vector-based vaccines use modified viruses to deliver target proteins, though they may cause more side effects.

  • Importance of limiting viral genes to reduce the incidence of side effects.

Ethical Considerations and Community Health

  • Acknowledgment of the ethical implications of vaccine distribution and public health initiatives.

  • Call for vigilance in monitoring virus mutations and emerging strains, particularly with zoonotic viruses like avian flu.

Conclusion

  • Encouragement for increased understanding of viruses, vaccines, and community health dynamics.

  • Suggestion for further reading and resources from organizations like the WHO and Health Protection Agency, particularly in the context of ongoing vaccine development and response to public health threats.

  • Open invitation for questions and further discussion on vaccine approaches and ongoing immunization challenges.